title: Interventional cardiology. Monitoring catheter ablation of AF--the European perspective.
abstract: Data from a prospective, European registry of patients undergoing catheter ablation of atrial fibrillation have now been published. The 1-year outcomes of this large, multinational study highlight variation in the concomitant use of antiarrhythmic drugs, and the need for rigorous clinical follow-up after ablation, with extended electrocardiographic monitoring.
authors.affiliation: Division of Cardiovascular Medicine, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5853, USA.
authors.forename: Rakesh
authors.initials: R
authors.lastname: Latchamsetty
authors.affiliation: Division of Cardiovascular Medicine, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5853, USA.
authors.forename: Hakan
authors.initials: H
authors.lastname: Oral
mesh_terms: D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D002309:Cardiology; D017115:Catheter Ablation / Q000009:adverse effects / Q000379:methods; D003452:Cryosurgery / Q000009:adverse effects / Q000379:methods; D004562:Electrocardiography; D005062:European Union; D019317:Evidence-Based Medicine; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D008991:Monitoring, Physiologic; D018579:Patient Selection; D011446:Prospective Studies; D011667:Pulmonary Veins; D055502:Secondary Prevention; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents